(Q37039851)

17 August 2017

Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience (English)

1 reference

17 August 2017

1 reference

1 reference

12

Eric Bouffet

1 reference

17 August 2017

1

Lucie Lafay-Cousin

1 reference

17 August 2017

Lillian Sung

2

1 reference

17 August 2017

Anne-Sophie Carret

3

1 reference

17 August 2017

Juliette Hukin

4

1 reference

17 August 2017

Beverly Wilson

5

1 reference

17 August 2017

Donna L Johnston

6

1 reference

17 August 2017

Shayna Zelcer

7

1 reference

17 August 2017

Mariana Silva

8

1 reference

17 August 2017

Isaac Odame

9

1 reference

17 August 2017

Chris Mpofu

10

1 reference

17 August 2017

Douglas Strother

11

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

17 August 2017

1 reference

17 August 2017

112

1 reference

17 August 2017

4

1 reference

17 August 2017

892-899

1 reference

The WHO classification of tumors of the nervous system

17 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

Clinical features of hypersensitivity reactions to carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Carboplatin hypersensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

[Hypersensitivity to carboplatin. An effect of generic drugs?]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Hypersensitivity to carboplatin in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Hypersensitivity reactions to carboplatin in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

[HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Development and implementation of a carboplatin desensitization protocol for children with neurofibromatosis, type 1 and hypersensitivity reactions in an outpatient oncology clinic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Outpatient carboplatin desensitization in a pediatric patient with bilateral optic glioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Successful carboplatin desensitization in patients with proven carboplatin allergy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Carboplatin hypersensitivity in children. A report of five patients with brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Weekly dosing of carboplatin increases risk of allergy in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Death from anaphylaxis to cisplatin: a case report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Anaphylaxis to carboplatin following multiple previous uncomplicated courses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23249

7 January 2021

Identifiers

DOI

10.1002/CNCR.23249

1 reference

17 August 2017

1 reference